Cargando…

MTX-13, a Novel PTK7-Directed Antibody–Drug Conjugate with Widened Therapeutic Index Shows Sustained Tumor Regressions for a Broader Spectrum of PTK7-Positive Tumors

Protein tyrosine kinase 7 (PTK7) is a Wnt signaling pathway protein implicated in cancer development and metastasis. When using a potent microtubule inhibitor (Aur0101), PTK7-targeting antibody–drug conjugate (ADC), h6M24-vc0101 (PF-06647020/cofetuzumab pelidotin) is efficacious only in limited tumo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kong, Chao, Pu, Junyi, Zhao, Qianqian, Weng, Weining, Ma, Linjie, Qian, Yu, Hu, Wenhao, Meng, Xun, Meng, Tao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Association for Cancer Research 2023
Materias:	First Disclosures
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10544008/ https://www.ncbi.nlm.nih.gov/pubmed/37352387 http://dx.doi.org/10.1158/1535-7163.MCT-23-0164

Ejemplares similares

AMT-562, a Novel HER3-targeting Antibody–Drug Conjugate, Demonstrates a Potential to Broaden Therapeutic Opportunities for HER3-expressing Tumors
por: Weng, Weining, et al.
Publicado: (2023)

Discovery and Preclinical Characterization of XMT-1660, an Optimized B7-H4-Targeted Antibody–Drug Conjugate for the Treatment of Cancer
por: Toader, Dorin, et al.
Publicado: (2023)

Preclinical Evaluation of 9MW2821, a Site-Specific Monomethyl Auristatin E–based Antibody–Drug Conjugate for Treatment of Nectin-4–expressing Cancers
por: Zhou, Wei, et al.
Publicado: (2023)

BT8009; A Nectin-4 Targeting Bicycle Toxin Conjugate for Treatment of Solid Tumors
por: Rigby, Michael, et al.
Publicado: (2022)

Datopotamab Deruxtecan, a Novel TROP2-directed Antibody–drug Conjugate, Demonstrates Potent Antitumor Activity by Efficient Drug Delivery to Tumor Cells
por: Okajima, Daisuke, et al.
Publicado: (2021)

Anti-PTK7 Monoclonal Antibodies Inhibit Angiogenesis by Suppressing PTK7 Function
por: Oh, Si Won, et al.
Publicado: (2022)

SGN-CD228A Is an Investigational CD228-Directed Antibody–Drug Conjugate with Potent Antitumor Activity across a Wide Spectrum of Preclinical Solid Tumor Models
por: Mazahreh, Rebecca, et al.
Publicado: (2023)

Vimseltinib: A Precision CSF1R Therapy for Tenosynovial Giant Cell Tumors and Diseases Promoted by Macrophages
por: Smith, Bryan D., et al.
Publicado: (2021)

PTK7 overexpression in colorectal tumors: Clinicopathological correlation and prognosis relevance
por: Tian, Xiuyun, et al.
Publicado: (2016)

PTK7 Faces the Wnt in Development and Disease
por: Berger, Hanna, et al.
Publicado: (2017)

A Novel Brain-Permeant Chemotherapeutic Agent for the Treatment of Brain Metastasis in Triple-Negative Breast Cancer
por: Deng, Jiaojiao, et al.
Publicado: (2021)

TPX-0131, a Potent CNS-penetrant, Next-generation Inhibitor of Wild-type ALK and ALK-resistant Mutations
por: Murray, Brion W., et al.
Publicado: (2021)

RP-3500: A Novel, Potent, and Selective ATR Inhibitor that is Effective in Preclinical Models as a Monotherapy and in Combination with PARP Inhibitors
por: Roulston, Anne, et al.
Publicado: (2022)

Discovery and Pharmacological Characterization of JNJ-64619178, a Novel Small-Molecule Inhibitor of PRMT5 with Potent Antitumor Activity
por: Brehmer, Dirk, et al.
Publicado: (2021)

A New Class of Selective ATM Inhibitors as Combination Partners of DNA Double-Strand Break Inducing Cancer Therapies
por: Zimmermann, Astrid, et al.
Publicado: (2022)

Anticancer Activity of ST101, A Novel Antagonist of CCAAT/Enhancer Binding Protein β
por: Darvishi, Emad, et al.
Publicado: (2022)

Discovery of STRO-002, a Novel Homogeneous ADC Targeting Folate Receptor Alpha, for the Treatment of Ovarian and Endometrial Cancers
por: Li, Xiaofan, et al.
Publicado: (2023)

Preclinical Evaluation of ON203, A Novel Bioengineered mAb Targeting Oxidized Macrophage Migration Inhibitory Factor as an Anticancer Therapeutic
por: Rossmueller, Gregor, et al.
Publicado: (2023)

Disclosures
Publicado: (2016)

Targeting treatment of bladder cancer using PTK7 aptamer-gemcitabine conjugate
por: Xiang, Wei, et al.
Publicado: (2022)

Ptk7 Marks the First Human Developmental EMT In Vitro
por: Chan, David N., et al.
Publicado: (2012)

Variants identified in PTK7 associated with neural tube defects
por: Lei, Yunping, et al.
Publicado: (2019)

PTK-7 Expression in Gastric Cancer: A Prognostic Determinant
por: Özçelik, Melike, et al.
Publicado: (2020)

The Increased PTK7 Expression Is a Malignant Factor in Cervical Cancer
por: Sun, Jun-Jie, et al.
Publicado: (2019)

The Mutational Landscape of PTK7 in Congenital Scoliosis and Adolescent Idiopathic Scoliosis
por: Su, Zhe, et al.
Publicado: (2021)

Identification and targeting of protein tyrosine kinase 7 (PTK7) as an immunotherapy candidate for neuroblastoma
por: Lee, Jasmine Y., et al.
Publicado: (2023)

Kinetochore microtubules in PTK cells
Publicado: (1992)

Repeated phototherapeutic keratectomy (PTK) followed by PTK with photorefractive keratectomy for anterior granular corneal dystrophy
por: Sridhar, Uma, et al.
Publicado: (2020)

Isolation of Human Colon Stem Cells Using Surface Expression of PTK7
por: Jung, Peter, et al.
Publicado: (2015)

Ptk7 and Mcc, Unfancied Components in Non-Canonical Wnt Signaling and Cancer
por: Dunn, Norris Ray, et al.
Publicado: (2016)

PTK7 is a novel oncogenic target for esophageal squamous cell carcinoma
por: Liu, Kang, et al.
Publicado: (2017)

PTK7-Targeting CAR T-Cells for the Treatment of Lung Cancer and Other Malignancies
por: Jie, Yamin, et al.
Publicado: (2021)

PTK7 is a positive allosteric modulator of GPR133 signaling in glioblastoma
por: Frenster, Joshua D., et al.
Publicado: (2023)

Interpolar spindle microtubules in PTK cells
Publicado: (1993)

Silencing of PTK7 in Colon Cancer Cells: Caspase-10-Dependent Apoptosis via Mitochondrial Pathway
por: Meng, Ling, et al.
Publicado: (2010)

Biphasic regulation of tumorigenesis by PTK7 expression level in esophageal squamous cell carcinoma
por: Shin, Won-Sik, et al.
Publicado: (2018)

PTEN is a protein phosphatase that targets active PTK6 and inhibits PTK6 oncogenic signaling in prostate cancer
por: Wozniak, Darren J., et al.
Publicado: (2017)

PTK 7 Is a Transforming Gene and Prognostic Marker for Breast Cancer and Nodal Metastasis Involvement
por: Gärtner, Silvia, et al.
Publicado: (2014)

Wnt, Ptk7, and FGFRL expression gradients control trunk positional identity in planarian regeneration
por: Lander, Rachel, et al.
Publicado: (2016)

Overexpression of the Promigratory and Prometastatic PTK7 Receptor Is Associated with an Adverse Clinical Outcome in Colorectal Cancer
por: Lhoumeau, Anne-Catherine, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_1h7t13n38g3gbnquc6anhcon0b